Cellular and Molecular Pathology

Our objectives reflect a comprehensive approach to medical research and disease management. By delving into the molecular and physiological mechanisms involved in disease and infection control, we can better understand how to specifically target the underlying causes of these conditions

Our objectives reflect a comprehensive approach to medical research and disease management. By delving into the molecular and physiological mechanisms involved in disease and infection control, we can better understand how to specifically target the underlying causes of these conditions. This knowledge can then be applied to identify genes or genetic expressions that could be useful in managing a range of therapies and conditions, including antiviral, anticancer, post-transplant, and psychiatric therapies. Genotyping allows us to identify patient subsets that could benefit from these therapies, which can be particularly useful in designing clinical trials or drug rescue programs. Additionally, by evaluating new and improved drug and drug target options, we can develop more effective treatments and bring innovative therapies to market.

The use of stem cell technology is another area of focus, particularly in implementing cell therapy procedures for patients suffering from malignant disorders, hepatic failure, and inborn congenital disorders. By harnessing stem cells’ regenerative potential, we can improve patient outcomes and provide more effective treatment options.

Overall, our objectives reflect a commitment to advancing medical research and improving patient care. By taking a multifaceted approach to disease management, we can make significant strides in developing new biomarkers for diagnosis and progression, new therapies, and improving existing treatments.

Expertise area includes molecular genetics, cellular and molecular pathology, multidrug resistance, interaction between host neuroimmune
Expertise area includes host-microbe interaction, tumor cell biology (signal transduction, epigenetic mechanisms, targeted anti-tumor and
Expertise area includes cancer cell signaling, targeted anti-cancer therapy, and immunotherapy.
FLORICA TOPÂRCEANU is senior researcher II at Cellular and Molecular Pathology Department. Expertise area includes
LILIA MATEI is senior researcher II at Cellular and Molecular Pathology Department. Expertise area includes
LAURA-DENISA DRAGU, is senior researcher II at Cellular and Molecular Pathology Department. Expertise area includes
ANA-IULIA NEAGU is scientific researcher III at Cellular and Molecular Pathology Department. Expertise area includes
CRISTINA MAMBET is a scientific researcher III at Cellular and Molecular Pathology Department. Expertise area
IOANA ALDEA-PITICA is scientific researcher III at Cellular and Molecular Pathology Department. Expertise includes cell
SAVIANA NEDEIANU is scientific researcher III at Cellular and Molecular Pathology Department. Expertise includes cell
ALINA SCHULMAN is scientific researcher III at Cellular and Molecular Pathology Department. Expertise includes immunofluorescence
MARIUS ATAMAN is researcher at Cellular and Molecular Pathology Department. Research interests: (1) Studies on
ELENA RADU is junior researcher at Cellular and Molecular Pathology Department. Expertise area includes antibiotic
Stoica S.I., Onose G., Pitica I.M., Neagu A.I., Ion G., Matei L., Dragu L.D., Radu L.-E., Chivu-Economescu M., Necula L.G. Molecular Aspects of Hypoxic Stress Effects in Chronic Ethanol Exposure of Neuronal Cells. Current Issues in Molecular Biology 2023, 45, 1655-1680.